Biotech · Private company
Endogenex, Inc.
Track this companyFree. Adds Endogenex, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Endogenex SystemType 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Endogenex TreatmentType 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Sham ProcedureType 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- The Endogenex DeviceDiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyNA · ENROLLING_BY_INVITATION · started Sep 1, 2026ClinicalTrials.gov NCT07197788 · fetched Nov 12, 2026
- Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)ENROLLING_BY_INVITATION · started Mar 11, 2026ClinicalTrials.gov NCT07197775 · fetched Nov 12, 2026
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesNA · ACTIVE_NOT_RECRUITING · started May 1, 2024ClinicalTrials.gov NCT06267391 · fetched Nov 12, 2026
- Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II DiabetesNA · COMPLETED · started Oct 29, 2021ClinicalTrials.gov NCT05014204 · fetched Nov 12, 2026